chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Start feeling tingling and numbness starting from my neck extending to my chin, lips, and cheeks. Having trouble in swallowing. Started 30-45 mins after getting the shot and continue up to new ( some improvements over time but not fully recovered)
About 2 weeks after the first dose I started having muscle spasms in the left side of my face. Frequency has increased after the second dose.. Second dose was on: March 18 2021 Pfizer Lot: en6207 administered by injection in left arm  no treatment or outcome has been pursued yet
pt recvd vax 1-1130AM on 18JUL94 pt c/o arm soreness but no sx fever on 18JUL94; pt refused supper; no excessive erythema or swelling @ inject site; pt awakened @ 530AM w/profuse nose bleed; again 7AM & 830AM pt vomited @ 1030AM x 3; fever
had shingles three times/Suspected vaccination failure; had shingles three times; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had shingles three times/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had shingles three times). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 26-MAR-2023 The case was received from the patient interactive digital media. The patient had the shingle vaccines and had shingles three times after but not as bad if he/she had not had the vaccine.  The patient always heard shingles would not cross over the side, but not true.  The patient stated that once shingles crossed over his/her back bone. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
10/29/12 - Pt received Tdap - flu - pneumonia 23. That evening, pt had slight swelling in (L) arm. 10/30/12 - Pt awoke with (L) arm swollen, warm to touch et fever. Did not take her own temp. Swollen on outside of arm to elbow. 11/1/12 - Softball size mark that red et swollen. No temp.
dizziness; shaking; tiredness; nauseated; shivering; initial headache; fever; This spontaneous case was reported by an other and describes the occurrence of DIZZINESS (dizziness), TREMOR (shaking), FATIGUE (tiredness), NAUSEA (nauseated) and CHILLS (shivering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), TREMOR (shaking), FATIGUE (tiredness), NAUSEA (nauseated), CHILLS (shivering), HEADACHE (initial headache) and PYREXIA (fever). At the time of the report, DIZZINESS (dizziness), FATIGUE (tiredness) and HEADACHE (initial headache) had resolved and TREMOR (shaking), NAUSEA (nauseated), CHILLS (shivering) and PYREXIA (fever) outcome was unknown.            The concomitant medications information was not reported. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: No specific follow-up information recorded.
GAVE VAXCHORA TO A 15-YEAR-OLD; A spontaneous case was received from a nurse on 24-Apr-2019 for two consumers.   Based on the information obtained from the nurse, two individual case safety reports PVX201904-000319 (PVX2019-985; 15-year-old male) and PVX201904-000320 (PVX2019-986, 16-year-old male) were created and cross-linked in the database.  It describes a 15-year-old adolescent male consumer whose nurse "gave Vaxchora to a 15-year-old". The consumer was receiving oral Vaxchora for cholera prophylaxis.  Case report: A 15-year-old male consumer had Vaxchora on 19-Apr-2019.  Action taken with Vaxchora with was not applicable.  The clinical outcome of the event "gave Vaxchora to a 15-year-old" was unknown.; Sender's Comments: Company's Comment: The causality of the event "gave Vaxchora to a 15-year-old" was considered as not applicable.
Information has been received from a physician concerning a 51 day old female infant with no known allergies and reflux who on 02-APR-2008 was vaccinated orally with a first dose of ROTATEQ (Oka/Merck) (lot # 659915/0015X). There was no concomitant medication. Subsequently, on 03-APR-2008 the patient experienced vomiting 2 to 4 times a day for 4 days after administration of the vaccine. Medical attention was sought in the office. There were no lab studies performed. The patient recovered on 07-APR-2008. There was no product quality complaint involved. Additional information has been requested.
Pt has h/o neuropathy; saw neurologist as routine after the shot given; had some numb strange sensations; he told her she had an ulnar neuropathy; she then kept the arm straight and a little hyperextended. She later noticed duskiness in the hand.
Three inch triangular shaped red rash that is itchy and a little swollen area at the site of injection.  On the day of vaccination it was a little sore.
PAIN AT INJECTION SITE RADIATING TO SHOULDER , AND STILL PRESENT ON 05 /27 /2021 ON DAY OF 2 ND INJECTION IN RIGHT ARM. THIS WAS REPORTED  TP TECH BEFORE 2 ND SHOT AND HE ADVISED ME TO GO TO SITE AND REPORT
Pt recvd 3 doses of Engerix-B vax & titers were checked 6 months p/last dose & titer result was 3.6, inidcating a low pos response;
Within five minutes, I experienced a hot, tingling, and metallic tasting sensation in my mouth, throat, and on my tongue. I started to feel an increase in my heart rate, experienced sweating, shaking, and shortness of breath. I was observed for 30 minutes and the symptoms lessened over that time. Driving home, I developed tingling and numbness in my face and  the odd sensation of hot/tingling/metallic in my mouth, throat, and on my tongue continues to come and go.
Patient only received a partial dose of the 0.25mL of the booster dose. The vaccine administered with the supplied vanish point syringe. The plunger did not depress the full amount and the patient only received  approximately 0.15mL of the dose. I contacted the manufacturer of the syringes. They verified the amount left in the syringe would be at 0.1mL base by where the plunger stops before the last press to retract the needle.
Globus feeling - feeling like "something caught in her throat", tingling lips, tongue felt "weird", tingling in legs.  Patient was monitored for approximate one hour total in the clinic.  Patient vital signs were stable at the beginning and continued to be stable.  No other signs or symptoms of an allergic reaction.
Information has been received from a pharmacist via a field representative concerning a male patient of unknown age. No concurrent condition, medical history and concomitant therapies were reported. On an unspecified date in February 2015, the patient was administered ZOSTAVAX (Lot#, dosage and route not provided) and developed a pock mark at the injection site shortly after the administration. The patient's pock mark at the injection site continually oozed, crusts over, then eventually the scab fell off and it started oozing again. It never healed. The patient visited several unspecified physicians regarding this issues but none of them were able to assist him. The pock mark had never completely healed. The patient was not recovered from the events at time of the reporting. The relationship between the events and ZOSTAVAX was not reported. Follow up information has been received on 15-JUN-2016 from a physician in the form of medical records and a 553A specimen form. According to medical records: The patient, now 83 years old, was seen by physician on 15-JUN-2016 for a wellness visit. The patient was noted to be a nonsmoker with no alcohol use with a medical history of left knee replacement (December 2008). The patient's family history included atrial fibrillation (mother), hypertension (mother and father), leukemia (father), basal cell carcinoma (father) and breast cancer (sister). The patient's current assessments included osteoarthritis, plantar fasciitis, essential hypertension benign, sick sinus syndrome, hyperlipidemia, vitamin D deficiency, obesity, basal cell carcinoma treated with Mohs surgery on forehead and back, and prostate cancer status post radiation. The patient also reported a fall within the last 3 months. Upon physical examination, the patient was noted to have a skin lesion on his right deltoid with no subcutaneous nodules or induration. The patient reported the skin lesion was following shingles vaccination about 1 and 1/2 years ago. The physician took a swab of the area and sent for evaluation upon the patient's request. The physician advised the patient to follow up with his dermatologist and possibly undergo a skin biopsy. The patient agreed to recommendation. According to the 553A specimen form: On 15-JUN-2016, a sample of the vesicle on the right deltoid was taken and sent for evaluation (VZVIP case number 1-14215671106). On 11-FEB-2015, an 82 year old male with a history of chicken pox in childhood was vaccinated with ZOSTAVAX, lot # K015308 in the left deltoid (in conflict, skin lesion noted on right deltoid and previously reported at injection site). A few days later, the patient experienced 2 itchy pimples (location not provided). The outcome of 2 itchy pimples was reported as recovered (date not provided). Upon internal review, sick sinus syndrome, basal cell carcinoma treated with Mohs surgery on forehead and back and prostate cancer status post radiation were considered to be medically significant. All available medical records will be provided upon request. Additional information has been requested.
Initial report was received from a healthcare professional on 29 October 2013. The reporter for this case is the same as the reporter for cases 2013SA111137 and 2013SA111180. A female patient (aged 65-years plus) received an injection of FLUZONE HIGH-DOSE (lot number, route, site and exact date of administration not reported) in October of 2013 and was hospitalized the day of vaccination with malaise, chills and treatment for pneumonia. The patient had no known allergies (NKA). Outcome was recovered. Documents held by sender: None.
I started with a sick throat, mild headache, cough, cranial pressure in my ears. A couple of days after, the sore throat got worse, felt like a razor blade was in my throat. My sister and brother are nurses so they advised me to take an at-home COVID-19 test which came back positive. The next day, I contacted my physician and informed them who later prescribed Paxlovid. As of today, I've taken my third dose and only have a minor sore throat, a slight cough, and minor nasal congestion; I'm not completely at 100% but making my way there.
Fever 7-10 days after Immun with rash approx (3-4) on face, diaper area, Varicella like rash at 12 days.
COVID-19; COVID-19; Interchange of vaccine products: Pfizer/ Moderna; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Nov2022 as dose 5 (booster), single (Lot number: 6J6738) at the age of 58 years, in left arm for COVID-19 immunisation; BNT162b2 (BNT162B2), on 18Mar2021 as dose 1, single (Lot number: EN6208), in left arm and on 08Apr2021 as dose 2, single (Lot number: EP7533), in left arm for COVID-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 19Nov2021 as dose 3 (booster), single (Lot number: 034F21A), in left arm and on 23Aug2022 as dose 4 (booster), single (Lot number: O118ZZA), in left arm for COVID-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing). Concomitant medication included: LOSARTAN, start date: 17Nov2022. Past drug history included: Cipro, reaction: "Known allergy". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 19Nov2021, outcome "unknown", described as "Interchange of vaccine products: Pfizer/ Moderna"; DRUG INEFFECTIVE (medically significant) with onset 03Feb2023, outcome "not recovered", COVID-19 (medically significant) with onset 03Feb2023, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03Feb2023) Positive; (11Feb2023) Negative; (12Feb2023) Negative; (17Feb2023) Positive. Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid from 05Feb2023 to 10Feb2023. Clinical course: The patient got COVID and started taking PAXLOVID from 05Feb (Day 3) in the evening for 5 days, then both 11Feb and 12Feb, she got negative COVID results with different test kit. On 15Feb and 16Feb nights, she got rash, 17Feb morning dry coughs and running nose, then she got again COVID positive.
vaccine was administered just outside the 12 hour window once it was punctured to patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine was administered just outside the 12 hour window once it was punctured to patient) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine was administered just outside the 12 hour window once it was punctured to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine was administered just outside the 12 hour window once it was punctured to patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Med Info Agent: Mensah Agyemang AE Submitted via Chatbot   Reporter did not allow further contact
Information was received from a consumer found on the Merck social media account, referring to her/his neighbor 'son, a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On an unknown date, the patient was vaccinated with unidentified Merck hpv vaccine (reported as "Know HPV"; name, lot number, expired date and dose were not provided) for prophylaxis. On the same day, he started seizing and was now epileptic. Even on medications, the patient had seizures all the time. The outcome of this event was unknown. Upon internal review, the event epileptic seizure was considered to be medically significant. Additional information is not expected, because there is no contact information provided.
pt states took vax 21JUL98 prior to dinner & felt fine that noc;went to work 22JUL98 fainted & was taken to ER;reporter did not feel that this is a rxn to the vaccine;
At 330 PM she had a itchy rash on her left arm - site of injection, entire back and neck. Her face and cheeks were burning. At 430 PM her doctor told her to take 1 CLARITIN, OTC with minimal improvement. At 7 PM patient took 1 ZYRTEC OTC with some improvement. Patient states that on 9/24 all symptoms subsided. She is taking ZYRTEC 1 tab BID for 1 week as advised by her physician.
Patient was waiting for the 15 minute wait time after receiving vaccine. After 5 minutes she said not feeling good and fell on the ground, she was so dizzy and short of breath, she used her inhaler to help her.  we lifted her legs upward and called 911 for help, meanwhile she started getting rash on arm and chest and side of abdomen. she then  decided to sit up  in chair while waiting for ambulance.  she didnt want to go with them to the hospital that they wanted to take her to. so she decided to call her mom to  pick her up and told 911 that she will take benadryl if needed because she was feeling better
After 2nd dose:  Chills, muscle aches, fatigue on the next day.; muscle ache; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration on 09Apr2021(at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 17Mar2021 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no allergies to medications, food, or other products. On 10Apr2021, after second dose, the patient experienced chills, muscle aches, fatigue on the next day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, muscle aches and fatigue was recovered on unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Individual fainted while walking to the medical area. Patient was brought by wheelchair to medical area. Loss of consciousness was approximately 1 minute. Patient laid on cot, vital signs all within normal limits. Patient recovered quickly and signed off on further medical assistance.
Patient had stated she felt well. 1-2 minutes later she c/o feeling woozy and was uncertain if her right hand was pale. + tingling. Brought to be evaluated by EMT.
I experienced minor sneezing, diarrhea , headaches, nostrils discomfort, lower right leg felt weird, back of my ears started itching and general bodily itches. All the symptoms have subsided except mild headaches and mild itches.
Was to have gotten a dose of Fluzone Quad but was given Pfizer Covid Vaccine instead.  It would have been her booster dose but given in error.
SOB, Congestion in lungs, postnasal drip. cold sweats, chest heaviness
Rushing feeling-hands turned red and warm and face turned red and warm; Rushing feeling-hands turned red and warm and face turned red and warm; redness of hands; Rushing feeling-hands turned red and warm and face turned red and warm; Palpitations-increases heart rate; Palpitations-increases heart rate; Increased blood pressure; This is a spontaneous report from a contactable Nurse.  A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 24Dec2020 at 04:15 (at the age of 43-years-old) at an unspecified dose in the left arm for COVID-19 vaccination. The patient's medical history was not reported. The patient was allergic to morphine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient was administered the vaccine in a workplace clinic. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 24Dec2020 at 04:30  the patient experienced a rushing feeling during which her hands turned red and warm and her face turned red and warm. At this same time, she also experienced increased blood pressure, palpitations and increases in her heart. The patient did not receive any treatment for the events. The clinical outcomes of rushing feeling during which her hands and face were warm and turned red, increased blood pressure, palpitations, increased heart rate were reported as recovered on an unspecified date in Dec2020. It was also reported that since the vaccination the patient had not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Pain; left forearm started burning and tingling; Bumps appear inside left forearm; Bumps appeared inside my left elbow; Tingling in left forearm/expanded over left torso; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling in left forearm/expanded over left torso), VACCINATION SITE MASS (Bumps appear inside left forearm), HERPES ZOSTER (Bumps appeared inside my left elbow), PAIN (Pain) and SKIN BURNING SENSATION (left forearm started burning and tingling) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 019B21A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC), VITAMIN D NOS and FISH OIL for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced PARAESTHESIA (Tingling in left forearm/expanded over left torso). On 24-May-2021, the patient experienced VACCINATION SITE MASS (Bumps appear inside left forearm) and HERPES ZOSTER (Bumps appeared inside my left elbow). On an unknown date, the patient experienced PAIN (Pain) and SKIN BURNING SENSATION (left forearm started burning and tingling). On 15-Aug-2021, HERPES ZOSTER (Bumps appeared inside my left elbow) had resolved. At the time of the report, PARAESTHESIA (Tingling in left forearm/expanded over left torso) and VACCINATION SITE MASS (Bumps appear inside left forearm) was resolving and PAIN (Pain) and SKIN BURNING SENSATION (left forearm started burning and tingling) outcome was unknown.            No treatment medications were reported. The event of Shingles was confirmed by two separate doctors according to the reporter.  Patient was on prolon diet(fast mimicking diet) from 17/05/2021 to 20/05/2021   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up received on 13-JUL-2021 and included contact information was updated. On 22-Aug-2021: Follow-up received: Pt. age, height, weight added. Added concomitant medication, new events (Pain, Skin burning sensation)were added, outcome of event updated, and narrative updated accordingly.
Immediate reaction at injection site (hive like bump) Within hours started spreading across arms and chest Called nurse hotline for Dr and recommended Benadryl..  within hours she had her face swollen whole body swollen
Fever of 101.1 and feeling chills on 7/26/22. Tested positive for COVID on that date.
Low grade fever and moderate chills approx. 12 hours after first dose. Headache the subsequent morning, with side effects gone after that following day, including slight arm pain. Six days later, developed sensitivity to the touch at the vaccine site, which went away after a day.